Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:2011:724871.
doi: 10.1155/2011/724871. Epub 2011 May 17.

When to initiate disease-modifying drugs for relapsing remitting multiple sclerosis in adults?

Mona Alkhawajah  1 , Joel Oger
Affiliations

When to initiate disease-modifying drugs for relapsing remitting multiple sclerosis in adults?

Mona Alkhawajah et al. Mult Scler Int. 2011.

Abstract

For patients with Relapsing Remitting Multiple Scierosis Beta Interfaerons and Glatiramer Acetate were the first to be licensed for treatment. This review deals with one major question: when to initiate therapy? Through exploring the unique characteristics of the disease and treatement we suggest an approach that should be helpful in the process of decision-making.

PubMed Disclaimer

References

    1. Rarlihof F, Filippi M, Horsfield MA, et al. Towards specific magnetic resonance imaging criteria in the early diagnosis of multiple sclerosis. Neurology. 1995;45(supplement 4):p. A338.
    1. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Annals of Neurology. 2005;58(6):840–846. - PubMed
    1. Traboulsee A. MRI relapses have significant pathologic and clinical implications in multiple sclerosis. Journal of the Neurological Sciences. 2007;256(supplement 1):S19–S22. - PubMed
    1. Weinshenker BG, Bass B, Rice GPA, et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain. 1989;112(1):133–146. - PubMed
    1. Goodin DS, Bates D. Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode. Multiple Sclerosis. 2009;15(10):1175–1182. - PubMed

LinkOut - more resources